Your browser doesn't support javascript.
loading
Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion.
Ohki, Kentaro; Kiyokawa, Nobutaka; Saito, Yuya; Hirabayashi, Shinsuke; Nakabayashi, Kazuhiko; Ichikawa, Hitoshi; Momozawa, Yukihide; Okamura, Kohji; Yoshimi, Ai; Ogata-Kawata, Hiroko; Sakamoto, Hiromi; Kato, Motohiro; Fukushima, Keitaro; Hasegawa, Daisuke; Fukushima, Hiroko; Imai, Masako; Kajiwara, Ryosuke; Koike, Takashi; Komori, Isao; Matsui, Atsushi; Mori, Makiko; Moriwaki, Koichi; Noguchi, Yasushi; Park, Myoung-Ja; Ueda, Takahiro; Yamamoto, Shohei; Matsuda, Koichi; Yoshida, Teruhiko; Matsumoto, Kenji; Hata, Kenichiro; Kubo, Michiaki; Matsubara, Yoichi; Takahashi, Hiroyuki; Fukushima, Takashi; Hayashi, Yasuhide; Koh, Katsuyoshi; Manabe, Atsushi; Ohara, Akira.
Afiliación
  • Ohki K; Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo oki-kn@ncchd.go.jp.
  • Kiyokawa N; Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo.
  • Saito Y; Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo.
  • Hirabayashi S; Department of Hematology/Oncology, Tokyo Metropolitan Children's Medical Center, Fuchu-shi.
  • Nakabayashi K; Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo.
  • Ichikawa H; Department of Pediatrics, St. Luke's International Hospital, Chuo-ku, Tokyo.
  • Momozawa Y; Department of Maternal-Fetal Biology, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo.
  • Okamura K; Fundamental Innovative Oncology Core, National Cancer Center Research Institute, Chuo-ku, Tokyo.
  • Yoshimi A; Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama-shi, Kanagawa.
  • Ogata-Kawata H; Department of Systems BioMedicine, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo.
  • Sakamoto H; Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo.
  • Kato M; Division of Pediatric Hematology and Oncology, Ibaraki Children's Hospital, Mito-shi.
  • Fukushima K; Department of Maternal-Fetal Biology, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo.
  • Hasegawa D; Fundamental Innovative Oncology Core, National Cancer Center Research Institute, Chuo-ku, Tokyo.
  • Fukushima H; Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo.
  • Imai M; Department of Pediatrics, Dokkyo Medical University, Tochigi.
  • Kajiwara R; Department of Pediatrics, St. Luke's International Hospital, Chuo-ku, Tokyo.
  • Koike T; Department of Pediatrics, University of Tsukuba Hospital, Ibaraki.
  • Komori I; Department of Pediatrics, Japanese Red Cross Musashino Hospital, Tokyo.
  • Matsui A; Department of Pediatrics, Yokohama City University Hospital, Kanagawa.
  • Mori M; Department of Pediatrics, Tokai University School of Medicine, Kanagawa.
  • Moriwaki K; Department of Pediatrics, Matsudo City Hospital, Chiba.
  • Noguchi Y; Department of Pediatrics, Japanese Red Cross Maebashi Hospital, Gunma.
  • Park MJ; Department of Hematology/Oncology, Saitama Children's Medical Center.
  • Ueda T; Department of Pediatrics, Saitama Medical Center, Saitama Medical University.
  • Yamamoto S; Department of Pediatrics, Japanese Red Cross Narita Hospital, Chiba.
  • Matsuda K; Department of Hematology/Oncology, Gunma Children's Medical Center, Shibukawa-shi.
  • Yoshida T; Department of Pediatrics, Nippon Medical School, Bunkyo-ku, Tokyo.
  • Matsumoto K; Department of Pediatrics, Showa University Fujigaoka Hospital, Yokohama-shi, Kanagawa.
  • Hata K; Laboratory of Clinical Genome Sequencing Department of Computational Biology and Medical Sciences Graduate School of Frontier Sciences, The University of Tokyo, Minato-ku.
  • Kubo M; Fundamental Innovative Oncology Core, National Cancer Center Research Institute, Chuo-ku, Tokyo.
  • Matsubara Y; Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo.
  • Takahashi H; Department of Maternal-Fetal Biology, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo.
  • Fukushima T; Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama-shi, Kanagawa.
  • Hayashi Y; Director, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo.
  • Koh K; Department of Pediatrics, Toho University Omori Medical Center, Tokyo.
  • Manabe A; Department of Child Health, Faculty of Medicine, University of Tsukuba, Ibaraki.
  • Ohara A; Institute of Physiology and Medicine, Jobu University, Takasaki-shi, Gunma, Japan.
Haematologica ; 104(1): 128-137, 2019 01.
Article en En | MEDLINE | ID: mdl-30171027
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Translocación Genética / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Proteínas de Fusión Oncogénica / Ribonucleoproteínas Nucleares Heterogéneas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: Haematologica Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Translocación Genética / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Proteínas de Fusión Oncogénica / Ribonucleoproteínas Nucleares Heterogéneas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Child / Female / Humans / Male Idioma: En Revista: Haematologica Año: 2019 Tipo del documento: Article